These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3092610)
21. Antiischaemic effects of phasic release nitroglycerin system during acute and sustained therapy. Krepp HP; Turpe F Eur Heart J; 1989 May; 10 Suppl A():36-42. PubMed ID: 2501093 [TBL] [Abstract][Full Text] [Related]
22. Baroreflex resetting but no vascular tolerance in response to transdermal glyceryl trinitrate in conscious rabbits. Serone AP; Angus JA; Wright CE Br J Pharmacol; 1996 May; 118(1):93-104. PubMed ID: 8733581 [TBL] [Abstract][Full Text] [Related]
23. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Ankolekar S; Fuller M; Cross I; Renton C; Cox P; Sprigg N; Siriwardena AN; Bath PM Stroke; 2013 Nov; 44(11):3120-8. PubMed ID: 24003041 [TBL] [Abstract][Full Text] [Related]
24. Assessment of dermal glyceryl trinitrate and isosorbide dinitrate for patients with angina pectoris. Hubner PJ; Jones PR; Galer IA Br Med J (Clin Res Ed); 1985 Feb; 290(6467):514-6. PubMed ID: 3918653 [TBL] [Abstract][Full Text] [Related]
25. Influence of transdermal nitrates on exercise capacity in patients with stable angina. Thompson R Angiology; 1986 Jun; 37(6):448-54. PubMed ID: 3089073 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of continuous and intermittent treatment with glyceryl trinitrate by the transdermal route in stable effort angina]. Bory M; Benaïch P; Panagides D; Desfossez L; Massiani PF; Bonnet JL Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):153-9. PubMed ID: 8054072 [TBL] [Abstract][Full Text] [Related]
27. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Gori T; Burstein JM; Ahmed S; Miner SE; Al-Hesayen A; Kelly S; Parker JD Circulation; 2001 Sep; 104(10):1119-23. PubMed ID: 11535566 [TBL] [Abstract][Full Text] [Related]
28. Amplification of glyceryl trinitrate-induced headache features by noxious craniofacial stimuli in pain-free healthy humans. Gazerani P; Cairns BE; Yassin H; Yousefi JT; Sherzaman AR; Nedergaard BS; Boldsen SK Pain Manag; 2019 Jan; 9(1):17-35. PubMed ID: 30501556 [TBL] [Abstract][Full Text] [Related]
29. Haemodynamic effects of glyceryl trinitrate following repeated application of a transdermal delivery system with a phasic release profile. Wiegand A; Bonn R; Wagner F; Trenk D; Jähnchen E Eur J Clin Pharmacol; 1991; 41(2):115-8. PubMed ID: 1743242 [TBL] [Abstract][Full Text] [Related]
30. Delayed migraine-like headache in healthy volunteers after a combination of acetazolamide and glyceryl trinitrate. Daugaard D; Thomsen LL; Iversen HK; Olesen J Cephalalgia; 2009 Dec; 29(12):1294-300. PubMed ID: 19438913 [TBL] [Abstract][Full Text] [Related]
31. Topical glyceryl trinitrate and noninsertional Achilles tendinopathy: a clinical and cellular investigation. Kane TP; Ismail M; Calder JD Am J Sports Med; 2008 Jun; 36(6):1160-3. PubMed ID: 18359821 [TBL] [Abstract][Full Text] [Related]
32. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate. Kelly EA; Ahmed RM; Horowitz JD Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990 [TBL] [Abstract][Full Text] [Related]
33. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Anderson ME; Moore TL; Hollis S; Jayson MI; King TA; Herrick AL Rheumatology (Oxford); 2002 Mar; 41(3):324-8. PubMed ID: 11934971 [TBL] [Abstract][Full Text] [Related]
34. Antianginal efficacy of a new nitroglycerin patch. Parker JO Eur Heart J; 1989 May; 10 Suppl A():43-9. PubMed ID: 2501094 [TBL] [Abstract][Full Text] [Related]
35. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris. Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056 [TBL] [Abstract][Full Text] [Related]
36. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion. Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313 [TBL] [Abstract][Full Text] [Related]
37. [Nitroglycerin patch for tocolysis--a prospective randomized comparison with fenoterol by infusion]. Schleussner E; Richter S; Gross W; Kähler C; Möller A; Möller U; Seewald HJ Z Geburtshilfe Neonatol; 2001; 205(5):189-94. PubMed ID: 11727665 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris. James MA; Walker PR; Papouchado M; Wilkinson PR Br Heart J; 1985 Jun; 53(6):631-5. PubMed ID: 3924081 [TBL] [Abstract][Full Text] [Related]
39. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker. Holdright DR; Katz RJ; Wright CA; Sparrow JL; Sullivan AK; Cunningham AD; Fox KM Br Heart J; 1993 Mar; 69(3):223-7. PubMed ID: 8096389 [TBL] [Abstract][Full Text] [Related]
40. Effect of glyceryl trinitrate on echocardiographic left ventricular dimensions during exercise in the upright position. Goldstein RE; Bennett ED; Leech GL Br Heart J; 1979 Sep; 42(3):245-54. PubMed ID: 116668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]